Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies - Concepedia

Concepedia

Publication | Open Access

Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies

DOI Full Paper Access

46

Citations

23

References

2021

Year

Fioravante Capone, Matteo Lucchini, Elisabetta Ferraro, Assunta Bianco, Mariagrazia Rossi, Alessandra Cicia, Antonio Cortese, Alessandro Cruciani, Valeria De Arcangelis, Laura De Giglio,

Neurotherapeutics

VaccinationVaccine SafetyVaccine DevelopmentDifferent Disease-modifying TherapiesMedicineImmunologyMrna Covid-19 VaccinesPrecision VaccinologyVaccine EfficacyMultiple SclerosisNeuroimmunologyVaccine ResearchViral ImmunityCovid-19

References

	Year	Citations

Page 1

Page 1